A review of the use of common antiplatelet agents in orthopaedic practice.
AffiliationDepartment of Orthopaedics, Cork University Hospital, Wilton, Cork, Republic of Ireland. email@example.com
MeSHAngioplasty, Balloon, Coronary
Drug Therapy, Combination
Platelet Aggregation Inhibitors
MetadataShow full item record
CitationA review of the use of common antiplatelet agents in orthopaedic practice. 2010, 92 (9):1186-91 J Bone Joint Surg Br
JournalThe Journal of bone and joint surgery. British volume
AbstractAntiplatelet agents are widely prescribed for the primary and secondary prevention of cardiovascular events. A common clinical problem facing orthopaedic and trauma surgeons is how to manage patients receiving these agents who require surgery, either electively or following trauma. The dilemma is to balance the risk of increased blood loss if the antiplatelet agents are continued peri-operatively against the risk of coronary artery/stent thrombosis and/or other vascular event if the drugs are stopped. The traditional approach of stopping these medications up to two weeks before surgery appears to pose significant danger to patients and may require review. This paper covers the important aspects regarding the two most commonly prescribed antiplatelet agents, aspirin and clopidogrel.
- Peri-operative management of antiplatelet therapy in patients with coronary artery disease: joint position paper by members of the working group on Perioperative Haemostasis of the Society on Thrombosis and Haemostasis Research (GTH), the working group on Perioperative Coagulation of the Austrian Society for Anesthesiology, Resuscitation and Intensive Care (ÖGARI) and the Working Group Thrombosis of the European Society for Cardiology (ESC).
- Authors: Korte W, Cattaneo M, Chassot PG, Eichinger S, von Heymann C, Hofmann N, Rickli H, Spannagl M, Ziegler B, Verheugt F, Huber K
- Issue date: 2011 May
- Impact of concomitant treatment with proton pump inhibitors and clopidogrel on clinical outcome in patients after coronary stent implantation.
- Authors: Tentzeris I, Jarai R, Farhan S, Brozovic I, Smetana P, Geppert A, Wojta J, Siller-Matula J, Huber K
- Issue date: 2010 Dec
- What is the role for improved long-term antiplatelet therapy after percutaneous coronary intervention?
- Authors: Steinhubl S, Berger P
- Issue date: 2003 Jun
- Increased long term rates of stent thrombosis and mortality in patients given clopidogrel as compared to ticlopidine following coronary stent implantation.
- Authors: Wolak A, Amit G, Cafri C, Gilutz H, Ilia R, Zahger D
- Issue date: 2005 Sep 1
- Ticlopidine and aspirin therapy following implantation of coronary artery stents.
- Authors: Hobson AG, Sowinski KM
- Issue date: 1997 Jun